NARCX
Price
$53.83
Change
-$0.02 (-0.04%)
Updated
Jan 22 closing price
Net Assets
291.16M
VFSAX
Price
$28.39
Change
-$0.04 (-0.14%)
Updated
Jan 22 closing price
Net Assets
10.41B
Ad is loading...

NARCX vs VFSAX

Header iconNARCX vs VFSAX Comparison
Open Charts NARCX vs VFSAXBanner chart's image
Voya Multi-Manager International Sm Cp C
Price$53.83
Change-$0.02 (-0.04%)
VolumeN/A
Net Assets291.16M
Vanguard FTSE All-Wld ex-US SmCp Idx Adm
Price$28.39
Change-$0.04 (-0.14%)
VolumeN/A
Net Assets10.41B
NARCX vs VFSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NARCX vs. VFSAX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NARCX is a Hold and VFSAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFSAX has more cash in the bank: 10.4B vs. NARCX (291M). VFSAX pays higher dividends than NARCX: VFSAX (3.01) vs NARCX (1.16). NARCX was incepted earlier than VFSAX: NARCX (30 years) vs VFSAX (6 years). NARCX is a more actively managed with annual turnover of: 90.00 vs. VFSAX (14.00). NARCX has a lower initial minimum investment than VFSAX: NARCX (1000) vs VFSAX (3000). NARCX annual gain was more profitable for investors over the last year : 9.87 vs. VFSAX (5.12). NARCX return over 5 years is better than : 14.82 vs. VFSAX (9.08).
NARCXVFSAXNARCX / VFSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years6 years-
Gain YTD2.6900.709379%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets291M10.4B3%
Annual Yield % from dividends1.163.0139%
Returns for 1 year9.875.12193%
Returns for 3 years4.37-6.26-70%
Returns for 5 years14.829.08163%
Returns for 10 years39.96N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EAFGX28.160.49
+1.77%
Eaton Vance Focused Growth Opps A
EEMHX8.020.02
+0.25%
MFS Emerging Markets Equity Research R6
JFNCX58.220.01
+0.02%
Janus Henderson Global Life Sciences C
VWYGX44.71N/A
N/A
Voya Small Cap Growth C
WOOPX19.12-0.10
-0.52%
JPMorgan SMID Cap Equity I